Empaveli
NDC 73606-010, Pegcetacoplan, injection, solution, from Apellis Pharmaceuticals, Inc..
- Product NDC
- 73606-010
- Status
- Listed
- Labeler
- Apellis Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215014
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73606-010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEGCETACOPLAN1080 mg/20mL
Pharmacologic classes
Complement Inhibitor [EPC]; Complement Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73606-010-01 | 73606001001 | 1 VIAL in 1 CARTON (73606-010-01) / 20 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c23d89e9-b00b-4520-e053-2995a90a95af
Use it
Look up 73606-010 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73606-010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73606-010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.